DMA Diamedica Therapeutics

Granite Creek Gold Ltd. (the "Company") (TSX VENTURE:GCX) is pleased to announce
that it has entered into a Consulting Agreement with Douglas McKay and
Associates ("DMA") to provide general marketing services to the Company in order
to raise the Company's public profile. The Agreement covers a term of six
months, which is renewable and subject to earlier termination by either party on
30 days advance written notice. DMA has extensive financial and marketing
knowledge and is based in Vanderhoof, BC. 


In consideration of the services to be provided, the Company has agreed to pay
DMA a monthly fee of C$5000 per month. Granite Creek has also agreed, subject to
TSX Venture Exchange approval, to grant DMA stock options for the purchase of up
to 500,000 common shares of the Company's capital stock for a period of five
years at a price of $0.10 per share in accordance with the Company's Stock
Option Plan and to vest according to TSX-V policy. 


About Granite Creek Gold 

Granite Creek is a Vancouver based exploration company in the business of
acquiring and carrying out exploration on mineral properties, especially those
with precious metals potential, with the goal of establishing a mineable mineral
resource. Granite Creek's BC projects consist of the gold/copper/molybdenum
Taseko Property, 225km north of Vancouver, on which it has an option to acquire
a 70% interest; the 100% owned 654ha Railway Property, a copper project in the
highly prospective Stikine arch area of northwestern British Columbia; and the
5611ha Troitsa Property, a copper/molybdenum/gold located in central British
Columbia, on which it has an option to acquire a 100% interest. Granite Creek's
Malian projects consist of the 35 sq km Koussikoto Ouest and the 75 sq km
Darsalam gold concessions in Mali, West Africa, both of which the Company has an
option to acquire a 100% interest. 


This news release includes certain forward-looking statements or information.
All statements other than statements of historical fact included in this
release, including, without limitation, statements relating to regulatory
approvals, exploration programs, and other future plans, objectives or
expectations of the Company are forward-looking statements that involve various
risks and uncertainties. There can be no assurance that such statements will
prove to be accurate and actual results and future events could differ
materially from those anticipated in such statements. Important factors that
could cause actual results to differ materially from the Company's plans or
expectations include the Company's ability to obtain regulatory approval and to
complete its exploration programs on schedule and other risks detailed herein
and from time to time in the filings made by the Company with securities
regulators. The Company expressly disclaims any intention or obligation to
update or revise any forward-looking statements whether as a result of new
information, future events or otherwise except as otherwise required by
applicable securities legislation. 


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Granite Creek Gold Ltd.
Timothy Johnson
President
604-569-2430
info@granitecreekgold.com

DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jun 2024 to Jul 2024

DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jul 2023 to Jul 2024